AAIC 2014 Highlights
Searchable 2014 program content, including session topics, speakers and abstracts, is now available.
SUMMARY and Q&A - David Knopman, M.D., a medical/scientific advisor to the Alzheimer's Association, discusses how smell and eye tests for markers of Alzheimer's disease may lead to simpler, less invasive methods of early detection.
SUMMARY and Q&A - William Klunk, M.D., Ph.D., vice chair of the Alzheimer's Association Medical and Scientific Advisory Council, highlights new research on Alzheimer's disease risk factors and possible protective behaviors.
SUMMARY and Q&A - Maria Carrillo, Ph.D., vice president of medical and scientific relations for the Alzheimer's Association, talks about the global number of cases of Alzheimer's disease and dementia, and the implications of new data from a handful of countries.
SUMMARY and Q&A - Ralph Nixon, Ph.D., chair of the Alzheimer's Association Medical and Scientific Advisory Council, discusses several noteworthy advances in research from AAIC 2014 that are being reported as "developing topics." These include a clinical trial of a lifetyle intervention and a third abnormal brain protein now linked to Alzheimer's disease.
Plenary speakers at AAIC
Register today to attend AAIC, where world renowned speakers will discuss the latest breakthroughs in dementia science. Hear from researchers like Eric Reiman, of the Banner Alzheimer’s Institute, John Morris, of Washington University St. Louis, or Geert Jan Biessels, of University Medical Center Utrecht Brain Center Rudolf Magnus.